ACHP Statement on “Most-Favored-Nation” Rx Pricing Executive Order
ACHP released a statement on the most-favored-nation prescription drug …
05/12/2025
Securing Affordable Treatments for All Americans
Anticompetitive practices within the pharmaceutical industry, coupled with outdated patent laws that inhibit more affordable biosimilars and generics, have resulted in skyrocketing drug costs for all Americans – but especially seniors and those with chronic conditions. ACHP advocates for sensible policies such as price transparency to rein in sky-high costs so that patients can afford the medications they need.
Facts & Figures
A Lifeline for Rare Diseases
Learn MoreRecent
Ending the Allure of Drug Advertising
ACHP calls on Congress to curb direct-to-consumer (DTC) drug ad …
04/10/2025
ACHP Statement on Final CY2026 MA and Part D Rule
ACHP President and CEO Ceci Connolly released a statement in …
04/04/2025
ACHP Letter to CMS Administrator Dr. Oz
ACHP sent a letter to CMS Administrator, Dr. Oz, with …
04/04/2025
Featured
OP-ED: What Could We Do if GLP-1 Weight Loss Drugs Were Free? Would Our Obesity Epidemic Be Solved for Good?
ACHP President and CEO Ceci Connolly coauthored an op-ed examining …
04/10/2024
PBMs are Clear as Mud: The Value of a Fee-Based, Transparent Model
Transparency in the drug supply chain is desperately needed to …
03/24/2025
Report Finds Improved Health & Greater Savings When Patients Take Their Medications as Prescribed
When people with diabetes follow their prescribed medical regimens, they …
11/10/2023
Sleeping Giants: How Employers Can Shape the Future of Health Care
Morgan Health CEO Dan Mendelson joins the Healthy Dialogue podcast …
09/13/2022
ACHP Applauds Senate Passage of Inflation Reduction Act
ACHP applauds the Senate for passing the Inflation Reduction Act, …
08/07/2022
Letter to Congressional Leadership on Ways to Improve Affordability in Health Care
The Alliance of Community Health Plans has sent Congressional Leaders …
04/25/2022
Ending the Allure of Drug Advertising
ACHP calls on Congress to curb direct-to-consumer (DTC) drug ad …
04/10/2025
Resource Library Search
Search by
ACHP Letter to Office of Management and Budget Director Vought on Deregulation in Health Care
ACHP urges the Trump Administration to pursue commonsense health care deregulation that eliminates waste, cuts costs, and empowers local health plans to deliver high-quality, affordable care.
05/16/2025
Chronic Disease Pledge Bright Spot: Baylor Scott & White Health Plan’s Diabetes Management Program
Texas-based ACHP member plan Baylor Scott & White Health Plan recognized what we all know: diabetes diagnoses are increasing and becoming more expensive to manage. When faced with this unfortunately …
05/15/2025
ACHP Statement on Energy & Commerce Committee Medicaid Markup
ACHP released a statement in response to the House Energy and Commerce's budget reconciliation markup.
05/14/2025
ACHP Statement on “Most-Favored-Nation” Rx Pricing Executive Order
ACHP released a statement on the most-favored-nation prescription drug pricing executive order.
05/12/2025
Loading…
